Cholesterol and non-cholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1: A review

Xenobiotica

Volumn 38, Issue 7-8, 2008, Pages 1119-1139

  Kidambi, S ^a   Patel, S B ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ABCG5; ABCG8; NPC1L1; Sterol transporters; Xenosterols

Indexed keywords

ATP BINDING CASSETTE TRANSPORTER G5; ATP BINDING CASSETTE TRANSPORTER G8; CARRIER PROTEIN; EZETIMIBE; NIEMAN PICK C1 LIKE 1 PROTEIN; PHYTOSTEROL;

BINDING AFFINITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; GENE EXPRESSION; GENE STRUCTURE; GENETIC POLYMORPHISM; GENOMICS; HUMAN; LIPID TRANSPORT; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PROTEOMICS; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE CANALICULI; BIOLOGICAL TRANSPORT; CHOLESTEROL; GASTROINTESTINAL TRACT; HUMANS; LIPID METABOLISM DISORDERS; LIPOPROTEINS; MEMBRANE PROTEINS; SITOSTEROLS;

EID: 48749087791     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250802007930     Document Type: Review

References (138)

1. Alrefai WA, Annaba F, Sarwar Z, Dwivedi A, Saksena S, Singla A, Dudeja PK, Gill RK. 2007. Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2. American Journal of Physiology and Gastrointestinal Liver Physiology 292(1):G369-G376.
2. Altmann SW, Davis Jr HR, Yao X, Laverty M, Compton DS, Zhu LJ, Crona JH, Caplen MA, Hoos LM, Tetzloff G, Priestly T, Burnett DA, Strader CD, Graziano MP. 2002. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochimica et Biophysica Acta 1580(1):77-93.
3. Altmann SW, Davis Jr HR, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, et al. 2004. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303(5661):1201-1204.
4. Ballantyne CM, Abate N, Yuan Z, King TR, Palmisano J. 2005. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) study. American Heart Journal 149(3):464-473.
5. Basso F, Freeman LA, Ko C, Joyce C, Amar MJ, Shamburek RD, Tansey T, Thomas F, Wu J, Paigen B, et al. 2007. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. Journal of Lipid Research 48(1):114-126.
6. Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, Lebeaut AP, Yang B, et al. 2001. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies. Clinical Therapy 23(8):1209-1230.
7. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH. 2000. Accumulation of dietary cholesterol in sitosterolaemia caused by mutations in adjacent ABC transporters. Science 290(5497):1771-1775.
8. Berge KE, Von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, Cohen JC. 2002. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. Journal of Lipid Research 43(3):486-494.
9. Bhattacharyya AK, Connor WE. 1974. Beta-sitosterolaemia and xanthomatosis. A newly described lipid storage disease in two sisters. Journal of Clinical Investigation 53(4):1033-1043.
10. Bosner MS, Lange LG, Stenson WF, Ostlund Jr RE. 1999. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. Journal of Lipid Research 40(2):302-308.
11. Brown JM, Rudel LL, Yu L. 2007. NPC1L1 (Niemann-Pick C1-like 1) mediates sterol-specific unidirectional transport of non-esterified cholesterol in McArdle-RH7777 hepatoma cells. Biochemistry Journal 406:273-283.
12. Buch S, Schafmayer C, Volzke H, Becker C, Franke A, Von Eller-Eberstein H, Kluck C, Bassmann I, Brosch M, Lammert F, et al. 2007. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nature Genetics 39(8):995-999.
13. Chan DC, Watts GF, Barrett PH, Whitfield AJ, Van Bockxmeer FM. 2004. ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men. Arteriosclererosis. Thrombosis and Vascular Biology 24(11):2188-2191.
14. Chan DC, Watts GF, Wang J, Hegele RA, Van Bockxmeer FM, Barrett PH. 2007. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men. Clinical Endocrinology (Oxford) [Epub ahead of print] doi: 10.1111/j.1365-2265.2007. 03144.X.
15. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, Hobbs HH. 2006. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proceedings of the National Academy of Sciences, USA 103(6):1810-1815.
16. Davies JP, Levy B, Ioannou YA. 2000. Evidence for a Niemann-Pick C (NPC) gene family: Identification and characterization of NPC1L1. Genomics 65(2):137-145.
17. Davies JP, Scott C, Oishi K, Liapis A, Ioannou YA. 2005. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. Journal of Biology and Chemistry 280(13):12710-12720.
18. Davis Jr HR, Compton DS, Hoos L, Tetzloff G. 2001. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arteriosclererosis. Thrombosis and Vascular Biology 21(12):2032-2038.
19. Davis Jr HR, Hoos LM, Tetzloff G, Maguire M, Zhu LJ, Graziano MP, Altmann SW. 2007. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice. Arteriosclererosis. Thrombosis and Vascular Biology 27(4):841-849.
20. Davis Jr HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, et al. 2004. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. Journal of Biology and Chemistry 279(32):33586-33592.
21. Dietschy JM, Turley SD. 2002. Control of cholesterol turnover in the mouse. Journal of Biology and Chemistry 277(6):3801-3804.
22. Dreesen TD, Johnson DH, Henikoff S. 1988. The brown protein of Drosophila melanogaster is similar to the white protein and to components of active transport complexes. Molecular Cell Biology 8(12):5206-5215.
23. Duan LP, Wang HH, Ohashi A, Wang DQ. 2006. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: Gender and age effects. American Journal of Physiology and Gastrointestinal Liver Physiology 290(2):G269-G276.
24. Duan LP, Wang HH, Wang DQ. 2004. Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. Journal of Lipid Research 45(7):1312-1323.
25. Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, Clavey V, Staels B, Lestavel S. 2006. Niemann-Pick C1-like 1 gene expression is down-regulated by LXR activators in the intestine. Biochemical and Biophysical Research Communications 340(4):1259-1263.
26. Field FJ, Born E, Mathur SN. 2004. Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick C1-like 1 protein gene expression. Journal of Lipid Research 45(12):2252-2259.
27. Freeman LA, Kennedy A, Wu J, Bark S, Remaley AT, Santamarina-Fojo S, Brewer Jr HB. 2004. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. Journal of Lipid Research 45(7):1197-1206.
28. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis Jr, HR, Dean DC, Detmers PA, et al. 2005. The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proceedings of the National Academy of Sciences, USA 102(23):8132-8137.
29. Geuken E, Visser DS, Leuvenink HG, De Jong KP, Peeters PM, Slooff MJ, Kuipers F, Porte RJ. 2005. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients. Hepatology 42(5):1166-1174.
30. Gould RG, Jones RJ, LeRoy GV, Wissler RW, Taylor CB. 1969. Absorbability of beta-sitosterol in humans. Metabolism 18(8):652-662.
31. Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, Hobbs HH. 2002. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. Journal of Clinical Investigation 110(5):659-669.
32. Graf GA, Yu L, Li WP, Gerard R, Tuma PL, Cohen JC, Hobbs HH. 2003. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. Journal of Biology and Chemistry 278(48):48275-48282.
33. Gregg RE, Connor WE, Lin DS, Brewer Jr HB. 1986. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. Journal of Clinical Investigation 77(6):1864-1872.
34. Groen AK, Oude Elferink RP. 2005. Lipid transport into bile and role in bile formation. Current Drug Targets and Immune Endocrine Metabolism Disorders 5(2):131-135.
35. Grunhage F, Acalovschi M, Tirziu S, Walier M, Wienker TF, Ciocan A, Mosteanu O, Sauerbruch T, Lammert F. 2007. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 46(3):793-801.
36. Gylling H. 2004. Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia. International Journal of Clinical Practice 58(9):859-866.
37. Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, Rauramaa R, Miettinen TA. 2004. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. Journal of Lipid Research 45(9):1660-1665.
38. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MI. 2000. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. European Journal of Clinical Nutrition 54(9):715-725.
39. Hauser H, Dyer JH, Nandy A, Vega MA, Werder M, Bieliauskaite E, Weber FE, Compassi S, Gemperli A, Boffelli D, et al. 1998. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 37(51):17843-17850.
40. Hawes BE, O'Neill K A, Yao X, Crona JH, Davis Jr HR, Graziano MP, Altmann SW. 2007. In vivo responsiveness to ezetimibe correlates with Niemann-Pick C1-like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Molecular Pharmacology 71(1):19-29.
41. Hazard SE, Patel SB. 2007. Sterolins ABCG5 and ABCG8: Regulators of whole body dietary sterols. Pflugers Archives 453(5):745-752.
42. Hegele RA, Guy J, Ban MR, Wang J. 2005. NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Lipids, Health and Disease 4:16.
43. Heinemann T, Axtmann G, Von Bergmann K. 1993. Comparison of intestinal absorption of cholesterol with different plant sterols in man. European Journal of Clinical Investigation 23(12):827-831.
44. Hubacek JA, Berge KE, Stefkova J, Pitha J, Skodova Z, Lanska V, Poledne R. 2004. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiology Research 53(4):395-401.
45. Iwayanagi Y, Takada T, Suzuki H. 2007. HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1. Pharmacology Research [Epub ahead of print] doi: 10.1007/S11095-007-9496-9.
46. Iyer SP, Yao X, Crona JH, Hoos LM, Tetzloff G, Davis Jr HR, Graziano MP, Altmann SW. 2005. Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochimica et Biophysica Acta 1722(3):282-292.
47. Kajinami K, Brousseau ME, Nartsupha C, Ordovas JM, Schaefer EJ. 2004a. ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. Journal of Lipid Research 45(4):653-656.
48. Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ. 2004b. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. Atherosclerosis 175(2):287-293.
49. Klett EL, Lu K, Kosters A, Vink E, Lee MH, Altenburg M, Shefer S, Batta AK, Yu H, Chen J, et al. 2004. A mouse model of sitosterolaemia: Absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Medicine 2:5.
50. Knopfel M, Davies JP, Duong PT, Kvaerno L, Carreira EM, Phillips MC, Ioannou YA, Hauser H. 2007. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane. Biochimica et Biophysica Acta 1771(9):1140-1147.
51. Kosters A, Frijters RJ, Kunne C, Vink E, Schneiders MS, Schaap FG, Nibbering CP, Patel SB, Groen AK. 2005. Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8. Hepatology 41(1):141-150.
52. Kosters A, Frijters RJ, Schaap FG, Vink E, Plosch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK. 2003. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. Journal of Hepatology 38(6):710-716.
53. Kosters A, Kunne C, Looije N, Patel SB, Oude Elferink RPJ, Groen AK. 2006. The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice. Journal of Lipid Research 47(9):1959-1966.
54. Kruit JK, Groen AK, Van Berkel TJ, Kuipers F. 2006. Emerging roles of the intestine in control of cholesterol metabolism. World Journal of Gastroenterology 12(40):6429-6439.
55. Kruit JK, Plosch T, Havinga R, Boverhof R, Groot PH, Groen AK, Kuipers F. 2005. Increased fecal neutral sterol loss upon liver X-receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 128(1):147-156.
56. Labonte ED, Howles PN, Granholm NA, Rojas JC, Davies JP, Ioannou YA, Hui DY. 2007. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochimica et Biophysica Acta 1771(9):1132-1139.
57. Lammert F, Wang DQ. 2005. New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology 129(2):718-734.
58. Langheim S, Yu L, Von Bergmann K, Lutjohann D, Xu F, Hobbs HH, Cohen JC. 2005. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. Journal of Lipid Research 46(8):1732-1738.
59. Lee MH, Gordon D, Ott J, Lu K, Ose L, Miettinen T, Gylling H, Stalenhoef AF, Pandya A, Hidaka H, et al. 2001a. Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities. European Journal of Human Genetics 9(5):375-384.
60. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, et al. 2001b. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nature Genetics 27(1):79-83.
61. Lees AM, Mok HY, Lees RS, McCluskey MA, Grundy SM. 1977. Plant sterols as cholesterol-lowering agents: Clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 28(3):325-338.
62. Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, Ose L, Stalenhoef AF, Mietinnen T, Bjorkhem I, et al. 2001. Two genes that map to the STSL locus cause sitosterolaemia: Genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. American Journal of Human Genetics 69(2):278-290.
63. Lu K, Lee MH, Yu H, Zhou Y, Sandell SA, Salen G, Patel SB. 2002. Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. Journal of Lipid Research 43(4):565-578.
64. Lutjohann D, Bjorkhem I, Beil UF, Von Bergmann K. 1995. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: Effect of sitostanol treatment. Journal of Lipid Research 36(8):1763-1773.
65. Lutjohann D, Von Bergmann K. 1997. Phytosterolaemia: Diagnosis, characterization and therapeutical approaches. Annals of Medicine 29(3):181-184.
66. Maxfield FR, McGraw TE. 2004. Endocytic recycling. Nature Reviews in Molecular Cell Biology 5(2):121-132.
67. Miettinen TA. 1980. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: A case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. European Journal of Clinical Investigation 10(1):27-35.
68. Miettinen TA, Klett EL, Gylling H, Isoniemi H, Patel SB. 2006. Liver transplantation in a patient with sitosterolaemia and cirrhosis. Gastroenterology 130(2):542-547.
69. Miettinen TA, Tilvis RS, Kesaniemi YA. 1990. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. American Journal of Epidemiology 131(1):20-31.
70. Miwa K, Inazu A, Kobayashi J, Higashikata T, Nohara A, Kawashiri M, Katsuda S, Takata M, Koizumi J, Mabuchi H. 2005. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects. Clinical Science (London) 109(2):183-188.
71. Morganroth J, Levy RI, McMahon AE, Gotto Jr. AM. 1974. Pseudohomozygous type II hyperlipoproteinemia. Journal of Pediatrics 85(5):639-643.
72. Mukherjee S, Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiology Reviews 77(3):759-803.
73. Muller M, Klein I, Kopacsi S, Remaley AT, Rajnavolgyi E, Sarkadi B, Varadi A. 2006. Co-expression of human ABCG5 and ABCG8 in insect cells generates an androstan stimulated membrane ATPase activity. FEBS Letters 580(26):6139-6144.
74. Normen AL, Brants HA, Voorrips LE, Andersson HA, Van den Brandt PA, Goldbohm RA. 2001. Plant sterol intakes and colorectal cancer risk in the Netherlands Cohort Study on Diet and Cancer. American Journal of Clinical Nutrition 74(1):141-148.
75. Normen L, Dutta P, Lia A, Andersson H. 2000. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. American Journal of Clinical Nutrition 71(4):908-913.
76. Okiyoneda T, Kono T, Niibori A, Harada K, Kusuhara H, Takada T, Shuto T, Suico MA, Sugiyama Y, Kai H. 2006. Calreticulin facilitates the cell surface expression of ABCG5/G8. Biochemical and Biophysical Research Communications 347(1):67-75.
77. Patel SB, Salen G, Hidaka H, Kwiterovich PO, Stalenhoef AF, Miettinen TA, Grundy SM, Lee MH, Rubenstein JS, Polymeropoulos MH, et al. 1998. Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. Journal of Clinical Investigation 102(5):1041-1044.
78. Plat J, Bragt MC, Mensink RP. 2005. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. Journal of Lipid Research 46(1):68-75.
79. Plosch T, Bloks VW, Terasawa Y, Berdy S, Siegler K, Van Der Sluijs F, Kema IP, Groen AK, Shan B, Kuipers F, et al. 2004. Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X-receptor. Gastroenterology 126(1):290-300.
80. Plosch T, Van der Veen JN, Havinga R, Huijkman NC, Bloks VW, Kuipers F. 2006. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice. American Journal of Physiology and Gastrointestinal Liver Physiology 291(3):G414-G423.
81. Popovich DG, Jenkins DJ, Kendall CW, Dierenfeld ES, Carroll RW, Tariq N, Vidgen E. 1997. The western lowland gorilla diet has implications for the health of humans and other hominoids. Journal of Nutrition 127(10):2000-2005.
82. Ratnayake WM, L'Abbe MR, Mueller R, Hayward S, Plouffe L, Hollywood R, Trick K. 2000. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. Journal of Nutrition 130(5):1166-1178.
83. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X-receptors alpha and beta. Journal of Biology and Chemistry 277(21):18793-18800.
84. Repa JJ, Buhman KK, Farese Jr RV, Dietschy JM, Turley SD. 2004. ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: Impact on hepatic cholesterol homeostasis. Hepatology 40(5):1088-1097.
85. Repa JJ, Mangelsdorf DJ. 2002. The liver X-receptor gene team: Potential new players in atherosclerosis. Nature Medicine 8(11):1243-1248.
86. Russell DW. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annual Reviews in Biochemistry 72:137-174.
87. Salen G, Ahrens Jr EH, Grundy SM. 1970. Metabolism of beta-sitosterol in man. Journal of Clinical Investigation 49(5):952-967.
88. Salen G, Kwiterovich Jr PO, Shefer S, Tint GS, Horak I, Shore V, Dayal B, Horak E. 1985. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. Journal of Lipid Research 26(2):203-209.
89. Salen G, Patel S, Batta AK. 2002. Sitosterolemia. Cardiovascular Drug Reviews 20(4):255-270.
90. Salen G, Shefer S, Nguyen L, Ness GC, Tint GS, Shore V. 1992. Sitosterolemia. Journal of Lipid Research 33(7):945-955.
91. Salen G, Von Bergmann K, Lutjohann D, Kwiterovich P, Kane J, Patel SB, Musliner T, Stein P, Musser B. 2004. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 109(8):966-971.
92. Sane AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Menard D, Beaulieu J-F, Levy E. 2006. Localization and role of NPC1L1 in cholesterol absorption in human intestine. Journal of Lipid Research. 47(10):2112-2120.
93. Schoenheimer R. 1929. Uber die Bedeutung der Pflanzensterine fur den tierischen Organismus. Hoppe Seyler's Zeitschrift für Physiologische Chemie 180:1-5.
94. Schoonjans K, Brendel C, Mangelsdorf D, Auwerx J. 2000. Sterols and gene expression: Control of affluence. Biochimica et Biophysica Acta 1529(1-3):114-125.
95. Scoggan KA, Gruber H, Lariviere K. 2003. A missense mutation in the Abcg5 gene causes phytosterolemia in SHR, stroke-prone SHR, and WKY rats. Journal of Lipid Research. 44(5):911-916.
96. Simmonds WJ, Hofmann AF, Theodor E. 1967. Absorption of cholesterol from a micellar solution: Intestinal perfusion studies in man. Journal of Clinical Investigation 46(5):874-890.
97. Simon JS, Karnoub MC, Devlin DJ, Arreaza MG, Qiu P, Monks SA, Severino ME, Deutsch P, Palmisano J, Sachs AB, et al. 2005. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment. Genomics 86(6):648-656.
98. Small DM. 2003. Role of ABC transporters in secretion of cholesterol from liver into bile. Proceedings of the National Academy of Sciences, USA 100(1):4-6.
99. Smart EJ, De Rose RA, Farber SA. 2004. Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proceedings of the National Academy of Sciences, USA 101(10):3450-3455.
100. Spector AA, Yorek MA. 1985. Membrane lipid composition and cellular function. Journal of Lipid Research 26(9):1015-1035.
101. Sudhop T, Lutjohann D, Von Bergmann K. 2005. Sterol transporters: Targets of natural sterols and new lipid lowering drugs. Pharmacology and Therapy 105(3):333-341.
102. Sullivan DT, Bell LA, Paton DR, Sullivan MC. 1979. Purine transport by malpighian tubules of pteridine-deficient eye color mutants of Drosophila melanogaster. Biochemistry and Genetics 17(5-6):565-573.
103. Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, Ohashi R, Ohguchi H, Okamura M, Kudo H, Daigo K, et al. 2007. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Molecular Cell Biology 27(12):4248-4260.
104. Tachibana S, Hirano M, Hirata T, Matsuo M, Ikeda I, Ueda K, Sato R. 2007. Cholesterol and plant sterol efflux from cultured intestinal epithelial cells is mediated by ATP-binding cassette transporters. Bioscience, Biotechnology and Biochemistry 71(8):1886-1895.
105. Tauscher A, Kuver R. 2003. ABCG5 and ABCG8 are expressed in gallbladder epithelial cells. Biochemistry and Biophysics Research Communications 307(4):1021-1028.
106. Tearle RG, Belote JM, McKeown M, Baker BS, Howells AJ. 1989. Cloning and characterization of the scarlet gene of Drosophila melanogaster. Genetics 122(3):595-606.
107. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, Yu L. 2007. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. Journal of Clinical Investigation 117(7):1968-1978.
108. Toth IE. 1992. Lipoprotein receptors and steroidogenesis in adrenocortical cells. Journal of Steroid Biochemistry and Molecular Biology 43(5):395-402.
109. Tremblay AJ, Lamarche B, Cohn JS, Hogue JC, Couture P. 2006. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia. Arteriosclererosis, Thrombosis and Vascular Biology 26(5):1101-1106.
110. Turley SD, Dietschy JM. 2003. Sterol absorption by the small intestine. Current Opinions in Lipidology 14(3):233-240.
111. Turley SD, Schwarz M, Spady DK, Dietschy JM. 1998. Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets. Hepatology 28(4):1088-1094.
112. Valasek MA, Weng J, Shaul PW, Anderson RGW, Repa JJ. 2005. Caveolin-1 is not required for murine intestinal cholesterol transport. Journal of Biology and Chemistry 280(30):28103-28109.
113. Van der Veen JN, Havinga R, Bloks VW, Groen AK, Kuipers F. 2007. Cholesterol feeding strongly reduces hepatic VLDL-triglyceride production in mice lacking the liver X-receptor alpha. Journal of Lipid Research 48(2):337-347.
114. Van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, Staels B, Groot PH, Groen AK, Kuipers F. 2005. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. Journal of Lipid Research 46(3):526-534.
115. Van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, Davis HR, Jr. 2000. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. British Journal of Pharmacology 129(8):1748-1754.
116. Van Heek M, Farley C, Compton DS, Hoos L, Davis HR. 2001. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. British Journal of Pharmacology 134(2):409-417.
117. Viturro E, De Oya M, Lasuncion MA, Gorgojo L, Moreno JM, Benavente M, Cano B, Garces C. 2006. Cholesterol and saturated fat intake determine the effect of polymorphisms at ABCG5/ABCG8 genes on lipid levels in children. Genetics and Medicine 8(9):594-599.
118. Vrins C, Vink E, Vandenberghe KE, Frijters R, Seppen J, Groen AK. 2007. The sterol transporting heterodimer ABCG5/ABCG8 requires bile salts to mediate cholesterol efflux. FEBS Letters 581(24):4616-4620.
119. Wang J, Sun F, Zhang D-W, Ma Y, Xu F, Belani JD, Cohen JC, Hobbs HH, Xie X-S. 2006a. Sterol transfer by ABCG5 and ABCG8: In vitro assay and reconstitution. Journal of Biology and Chemistry 281(38):27894-27904.
120. Wang J, Williams CM, Hegele RA. 2005. Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe. Clinical Genetics 67(2):175-177.
121. Wang Y, Jiang ZY, Fei J, Xin L, Cai Q, Jiang ZH, Zhu ZG, Han TQ, Zhang SD. 2007. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clinica et Chimica Acta 384(1-2):80-85.
122. Wang Z, Stalcup LD, Harvey BJ, Weber J, Chloupkova M, Dumont ME, Dean M, Urbatsch IL. 2006b. Purification and ATP hydrolysis of the putative cholesterol transporters ABCG5 and ABCG8. Biochemistry 45(32):9929-9939.
123. Weihrauch JL, Gardner JM. 1978. Sterol content of foods of plant origin. Journal of the American Diet Association 73(1):39-47.
124. Weinglass AB, Kohler MG, Nketiah EO, Liu J, Schmalhofer W, Thomas A, Williams B, Beers L, Smith L, Hafey M, et al. 2008. MDCKII cells: A pharmacologically validated system for NPC1L1-mediated cholesterol uptake. Molecular Pharmacology 73(4):1072-1084.
125. Wendler F, Franch-Marro X, Vincent JP. 2006. How does cholesterol affect the way Hedgehog works? Development 133(16):3055-3061.
126. Wittenburg H, Carey MC. 2002. Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8. Journal of Clinical Investigation 110(5):605-609.
127. Wittenburg H, Lyons MA, Li R, Kurtz U, Mossner J, Churchill GA, Carey MC, Paigen B. 2005. Association of a lithogenic Abcg5/Abcg8 allele on Chromosome 17 (Lith9) with cholesterol gallstone formation in PERA/EiJ mice. Mammalian Genome 16(7):495-504.
128. Yamagishi S, Nakamura K, Matsui T, Sato T, Takeuchi M. 2006. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver. Medical Hypotheses 66(4):844-844.
129. Yamanashi Y, Takada T, Suzuki H. 2007. Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol uptake in CaCo-2 cells. Journal of Pharmacology and Experimental Therapy 320(2):559-564.
130. Yeagle PL. 1985. Cholesterol and the cell membrane. Biochimica et Biophysica Acta 822(3-4):267-287.
131. Yu H, Pandit B, Klett E, Lee MH, Lu K, Helou K, Ikeda I, Egashira N, Sato M, Klein R, et al. 2003a. The rat STSL locus: Characterization, chromosomal assignment, and genetic variations in sitosterolemic hypertensive rats. BMC Cardiovascular Disorders 3:4.
132. Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, Michaely P, Liu P, Willingham MC, Rudel LL. 2006. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. Journal of Biology and Chemistry 281(10):6616-6624.
133. Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC. 2005a. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. Journal of Biology and Chemistry 280(10):8742-8747.
134. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. 2002a. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proceedings of the National Academy of Sciences, USA 99(25):16237-16242.
135. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH. 2002b. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. Journal of Clinical Investigation 110(5):671-680.
136. Yu L, Von Bergmann K, Lutjohann D, Hobbs HH, Cohen JC. 2004. Selective sterol accumulation in ABCG5/ABCG8-deficient mice. Journal of Lipid Research 45(2):301-307.
137. Yu L, Von Bergmann K, Lutjohann D, Hobbs HH, Cohen JC. 2005b. Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8. Journal of Lipid Research 46(8):1739-1744.
138. Yu L, York J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. 2003b. Stimulation of cholesterol excretion by the liver X-receptor agonist requires ATP-binding cassette transporters G5 and G8. Journal of Biology and Chemistry 278(18):15565-15570.